Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone implant vs oral naltrexone for heroin addiction
NCT00218426Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of naltrexone in heroin dependence, opioid use disorder (OUD), sponsored by University of Pennsylvania. Started Jul 2006; status: completed.
02
Drugs
naltrexone
03
Conditions
heroin dependenceopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00218426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218426.